Xeris Pharmaceuticals, Inc. Gains 29.24%

Mon, May 16, 2022 at 05:30 PM
Xeris Pharmaceuticals, Inc. Gains 29.24%

Xeris Pharmaceuticals, Inc. (XERS:NASDAQ) soared at $2.21, a gain of 29.2%. The stock appeared on our News Catalysts scanner on Thu, May 12, 2022 at 04:47 PM in the 'BIOTECH' category. From Mon, May 02, 2022, the stock recorded 11.11% Up Days and 30.00% Green Days

The stock spiked on Fri, Mar 18, 2022 at $2.95 with a volume of 2M+.

About Xeris Pharmaceuticals, Inc. (XERS:NASDAQ)

Xeris Pharmaceuticals Inc is a specialty pharmaceutical company leveraging its novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.